topic

Pan-cancer analysis of CD274 (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression
Richard S.P. Huang, Brennan Decker, Karthikeyan Murugesan, Matthew Hiemenz, Douglas A. Mata, Gerald Li, James Creeden, Shakti H. Ramkissoon, Jeffrey S. Ross

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002558; DOI: 10.1136/jitc-2021-002558
Correction: Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) 1; DOI: 10.1136/jitc-2020-001930corr1
Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma
Yuxiang Ma, Xi Chen, Ao Wang, Hongyun Zhao, Qingguang Lin, Hua Bao, Yang Zhang, Shaodong Hong, Wanxiangfu Tang, Yan Huang, Yunpeng Yang, Xue Wu, Yang Shao, Wenfeng Fang, Li Zhang

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e002014; DOI: 10.1136/jitc-2020-002014
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
Angelika M Starzer, Anna S Berghoff, Rainer Hamacher, Erwin Tomasich, Katharina Feldmann, Teresa Hatziioannou, Stefan Traint, Wolfgang Lamm, Iris M Noebauer-Huhmann, Julia Furtner, Leonhard Müllauer, Gabriele Amann, Sebastian Bauer, Hans-Ulrich Schildhaus, Matthias Preusser, Gerwin Heller, Thomas Brodowicz

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e001458; DOI: 10.1136/jitc-2020-001458
Host response to immune checkpoint inhibitors contributes to tumor aggressiveness
Irina Khononov, Eyal Jacob, Ella Fremder, Nili Dahan, Michal Harel, Ziv Raviv, Boris Krastev, Yuval Shaked

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e001996; DOI: 10.1136/jitc-2020-001996
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
François Anna, Elodie Bole-Richard, Joel LeMaoult, Marie Escande, Martin Lecomte, Jean-Marie Certoux, Philippe Souque, Francine Garnache, Olivier Adotevi, Pierre Langlade-Demoyen, Maria Loustau, Julien Caumartin

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e001998; DOI: 10.1136/jitc-2020-001998
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
Marie-Léa Gauci, Barouyr Baroudjian, Celeste Lebbe, Olivier Roux

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e002337; DOI: 10.1136/jitc-2021-002337
Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity
Daan F Boreel, Paul N Span, Johan Bussink

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e001793; DOI: 10.1136/jitc-2020-001793
Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic
Renee N Donahue, Jennifer L Marté, Meghali Goswami, Nicole J Toney, Yo-Ting Tsai, James L Gulley, Jeffrey Schlom

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e002087; DOI: 10.1136/jitc-2020-002087
Narrowband ultraviolet B therapy for refractory immune-related lichenoid dermatitis on PD-1 therapy: a case report
Khashayar Esfahani, Meagan-Helen Henderson Berg, Hanieh Zargham, Robin Billick, Kevin Pehr, Margaret Redpath, Osama Roshdy, Wilson H Miller

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e001831; DOI: 10.1136/jitc-2020-001831

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages